text_1: Exhaustion of B cells contributes to poor Ab response in HIV-infected individuals.
text_2: Current HIV vaccine candidates do not elicit neutralizing antibodies against most circulating virus strains, and thus the induction of a protective antibody response remains a major priority for HIV-1 vaccine development.